Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China

SHANGHAI, Dec. 3, 2023. Everest Medicines ( " Everest " , or the " Company " ), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that China National Medical...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials